RxDoctor Payments Data

Shandora Hayman Jones, NP

Nurse Practitioner · Macon, GANPI 1487663480

Payments from drug & device makers

$5,402in general payments, 2019–2025

Across 292 payments — averaging $18.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$735
  • Astellas Pharma US Inc$370
  • AbbVie$365
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$308
  • Pfizer$260
  • Amgen$222
  • plus $3K from 53 others

What the payments were for

  • Food & beverage$5,21997%
  • Education$1833%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk37$735
Astellas Pharma US Inc15$370
AbbVie(2 entities)21$365
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC17$308
Pfizer16$260
Amgen(2 entities)14$222
Novartis13$212
AstraZeneca(2 entities)12$206
Otsuka America Pharmaceutical, Inc.8$206
Noven Therapeutics, LLC10$189
Lilly USA, LLC11$182
Bayer7$151
GSK7$107
Antares Pharma, Inc.6$105
Takeda Pharmaceuticals U.S.A., Inc.5$104
Teva Pharmaceuticals USA, Inc.6$98
Ironwood Pharmaceuticals, Inc4$87
Corium, LLC3$85
Sumitomo Pharma America, Inc.4$78
Abbott5$76
Phathom Pharmaceuticals, Inc.4$75
Biohaven Pharmaceutical Holding Company Ltd.5$73
Biohaven Pharmaceuticals, Inc.5$70
Sunovion Pharmaceuticals Inc.3$67
Merck3$59
Johnson & Johnson3$54
Shield Therapeutics Inc3$52
Neos Therapeutics, LP3$49
Upsher-smith Laboratories LLC3$49
Dexcom, Inc.3$42
Ardelyx, Inc.2$42
Lundbeck LLC2$40
Baxter Healthcare1$39
Sanofi-aventis U.S. LLC2$36
Nestle Healthcare Nutrition Inc.2$33
Eisai Inc.2$32
Axsome Therapeutics, Inc.1$28
UCB, Inc.1$28
Ascensia Diabetes Care US Inc.2$28
Boehringer Ingelheim2$26
Vertex1$26
Bausch Health US, LLC1$24
Amarin Pharma, Inc.1$23
Scilex Pharmaceuticals Inc.1$22
Evoke Pharma, Inc.1$22
Ironshore Pharmaceuticals Inc.1$20
Mannkind Corporation1$19
Hologic Sales And Service, LLC1$19
ARS Pharmaceuticals Operations, Inc.1$18
Idorsia Pharmaceuticals US Inc1$18
Corcept Therapeutics1$17
Kowa Pharmaceuticals America, Inc.1$16
Mylan Pharmaceuticals Inc.1$15
Exact Sciences1$14
Amneal Pharmaceuticals LLC1$14
Jazz Pharmaceuticals Inc.1$14
Esperion Therapeutics, Inc.1$12
E.r. Squibb & Sons, L.L.C.1$12
Genentech USA, Inc.1$9

How this compares

$5,402 in reported general payments places this provider in the 95th percentile of 3,328 nurse practitioner providers in Georgia.

See all nurse practitioner providers in Georgia

Medicare billing

Part B allowed, 2024
$97,902
Medicare patients
408
Services billed
2,463

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide25$34,956
MounjaroTirzepatide18$22,716
EliquisApixaban17$13,949
JardianceEmpagliflozin15$11,370
Testosterone11$2,245
Testosterone Cypionate42$1,358
Pregabalin34$1,165
SynthroidLevothyroxine Sodium11$909
Levothyroxine Sodium74$833
ProgesteroneProgesterone, Micronized31$818
Aripiprazole18$604
Gabapentin46$602
Rosuvastatin Calcium49$574
Albuterol Sulfate HfaAlbuterol Sulfate17$545
Alprazolam156$524

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$735$34,95625 claims
Lilly USA, LLCMounjaro$182$22,71618 claims
PfizerEliquis$260$13,94917 claims
Boehringer IngelheimJardiance$26$11,37015 claims
AbbVieSynthroid$365$90911 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$14$83374 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,328 nurse practitioner providers in Georgia.

Other nurse practitioner in Macon

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →